ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000266801.1	ABT-263 (navitoclax)	Skin cutaneous melanoma	0.030702945	Resistant
ENSG00000266801.1	ABT-263 (navitoclax)	Breast invasive carcinoma	0.046211536	Sensitive